RPM Platform Helps Manage Gestational Diabetes 
|
By HospiMedica International staff writers Posted on 14 Sep 2021 |
|
Image: The Smart Meter iGlucose BGM system (Photo courtesy of Smart Meter)
A cellular-connected blood glucose remote patient monitoring (RPM) device provides simplified and improved patient care and support during pregnancy.
The Smart Meter (Tamps, FL, USA) iGlucose Blood Glucose Monitoring (BGM) system is an out-of-the-box ready device for patients of all ages that provides reliable and immediate cellular transmission of blood glucose readings via the proprietary AutoShare feature, thereby eliminating the need for logbooks, faxes, and avoidable phone calls. In addition, Autoshare eliminates complicated Bluetooth pairing, syncing, and uploading by providing a seamless cellular connectivity experience.
Results can be viewed immediately by care providers, who can react in real-time to adjust diet or medication, potentially reducing care costs and trips to the hospital. The BGM is accompanied by the iGlucose virtual coach, which communicates with the user via text and email messages, reminders and alerts, notification of blood glucose results, and messages sent to engage the user’s circle of care. In addition, BGM includes the iGlucose personal web portal, which automatically generates logbook and reports.
“We've seen great success with our iGlucose monitors in other markets, such as long-term care (LTC), and we're thrilled to now offer our solution to support women with gestational diabetes,” said Casey Pittock, CEO of Smart Meter. “Pregnancy can be a stressful time. iGlucose can help provide peace of mind that patients are getting the best care and support possible.”
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The definition applies whether insulin or only diet modification is used for treatment, and whether or not the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy. About 7% of all pregnancies are complicated by GDM, with a prevalence of 1-14% of all pregnancies, depending on the population studied and the diagnostic tests employed.
Related Links:
Smart Meter
The Smart Meter (Tamps, FL, USA) iGlucose Blood Glucose Monitoring (BGM) system is an out-of-the-box ready device for patients of all ages that provides reliable and immediate cellular transmission of blood glucose readings via the proprietary AutoShare feature, thereby eliminating the need for logbooks, faxes, and avoidable phone calls. In addition, Autoshare eliminates complicated Bluetooth pairing, syncing, and uploading by providing a seamless cellular connectivity experience.
Results can be viewed immediately by care providers, who can react in real-time to adjust diet or medication, potentially reducing care costs and trips to the hospital. The BGM is accompanied by the iGlucose virtual coach, which communicates with the user via text and email messages, reminders and alerts, notification of blood glucose results, and messages sent to engage the user’s circle of care. In addition, BGM includes the iGlucose personal web portal, which automatically generates logbook and reports.
“We've seen great success with our iGlucose monitors in other markets, such as long-term care (LTC), and we're thrilled to now offer our solution to support women with gestational diabetes,” said Casey Pittock, CEO of Smart Meter. “Pregnancy can be a stressful time. iGlucose can help provide peace of mind that patients are getting the best care and support possible.”
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The definition applies whether insulin or only diet modification is used for treatment, and whether or not the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy. About 7% of all pregnancies are complicated by GDM, with a prevalence of 1-14% of all pregnancies, depending on the population studied and the diagnostic tests employed.
Related Links:
Smart Meter
Gold Member
12-Channel ECG
CM1200B
New
Medical Adhesive
MED 5570U
New
Tourniquet System
heidi– mein Tourniquet
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
